| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18826750 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 97 journal articles in the PubMed database | Email to a friend | | |
| Tunis SL, Minshall ME, Charles MS, et al.
Pioglitazone versus rosiglitazone treatment in patients with type 2 diabetes and dyslipidemia: cost-effectiveness in the US. [JOURNAL ARTICLE]
Curr Med Res Opin 2008 Sep 29.
Abstract | Full Citation | Find Related Articles | | Plosker GL, Figgitt DP
Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus. [Journal Article, Review]
Pharmacoeconomics 2004; 22(6):389-411.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Tilden DP, Mariz S, O'bryan-Tear G, et al.
A Lifetime Modelled Economic Evaluation Comparing Pioglitazone and Rosiglitazone for the Treatment of Type 2 Diabetes Mellitus in the UK. [Journal Article]
Pharmacoeconomics 2007; 25(1):39-54.
Abstract | Full Citation | | Valentine WJ, Bottomley JM, Palmer AJ, et al.
PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK. [JOURNAL ARTICLE]
Diabet Med 2007 Jun 25.
Abstract | Full Citation | | Derosa G, Cicero AF, D'Angelo A, et al.
Effects of 1 Year of Treatment with Pioglitazone or Rosiglitazone Added to Glimepiride on Lipoprotein (a) and Homocysteine Concentrations in Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome: A Multicenter, Randomized, Double-Blind, Controlled Clinical Trial. [Journal Article]
Clin Ther 2006 May; 28(5):679-88.
Abstract | Full Citation | | Herz M, Johns D, Reviriego J, et al.
A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Clin Ther 2003 Apr; 25(4):1074-95.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Czoski-Murray C, Warren E, Chilcott J, et al.
Clinical effectiveness and cost-effectiveness of pioglitazone and rosiglitazone in the treatment of type 2 diabetes: a systematic review and economic evaluation. [Journal Article, Review]
Health Technol Assess 2004 Apr; 8(13):iii, ix-x, 1-91.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Valentine WJ, Palmer AJ, Lammert M, et al.
Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin naïve type 2 diabetes patients: cost-effectiveness analysis in the UK setting. [Journal Article]
Curr Med Res Opin 2005 Dec; 21(12):2063-71.
Abstract | Full Citation | Find Related Articles | | Olansky L, Marchetti A, Lau H
Multicenter retrospective assessment of thiazolidinedione monotherapy and combination therapy in patients with type 2 diabetes: comparative subgroup analyses of glycemic control and blood lipid levels. [Journal Article, Review]
Clin Ther 2003.:B64-80.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
Advertise on this site.
|
